New Era of Preventing End-Stage Kidney Disease Act
Sponsored by Gus M. Bilirakis RRepublican, introduced . Policy area, as Congress files it: Health.
Status is read from the official actions by their Library of Congress codes: Became Public Law (36000) or a law number on the bill reads "Became law"; Vetoed (31000) reads "Vetoed"; Presented to President (28000) reads "Sent to the President"; passed or agreed to in the House (8000) and in the Senate (17000) reads "Passed both chambers"; one of them alone reads "Passed the House" or "Passed the Senate" ("Agreed to" for a resolution); reported to the House (5000) or the Senate (14000) reads "Reported by committee"; anything else reads "Introduced".
Source: Congress.gov data service (Library of Congress). Text versions: our copies of govinfo.gov’s files. Our copy was saved October 14, 2026.
Cosponsors
63 cosponsors.
Text
| Version | Date | Our copy |
|---|---|---|
| Introduced in House | Read our copyThe official file |
Actions
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Introduced in House
- Introduced in House
Committees
- Ways and Means Committee (House)Referred To, February 24, 2025
- Energy and Commerce Committee (House)Referred To, February 24, 2025
Hearings
We hold hearing records only for bills that became law.
Who lobbied on this bill
Confirmed from the official record6 lobbying reports name H.R. 1518, for 5 clients.
| Client | Registrant | Amount for the whole quarter | Lobbyists named for this issue | Filed | Report |
|---|---|---|---|---|---|
| TRAVERE THERAPEUTICS | TRAVERE THERAPEUTICSSecond quarter of 2026 | $140,000reported as expenses |
| Open the report | |
| VERTEX PHARMACEUTICALS | TIBER CREEK GROUPSecond quarter of 2026 | $60,000reported as income |
| Open the report | |
| AMERICAN SOCIETY OF NEPHROLOGY | AMERICAN SOCIETY OF NEPHROLOGYSecond quarter of 2026 | $60,000reported as expenses |
| Open the report | |
| VERTEX PHARMACEUTICALS INCORPORATED | VERTEX PHARMACEUTICALS INCORPORATEDSecond quarter of 2026 | $1,200,000reported as expenses |
| Open the report | |
| OTSUKA AMERICA PHARMACEUTICAL, INC. | OTSUKA AMERICA PHARMACEUTICAL, INC.Second quarter of 2026 | $1,240,000reported as expenses |
| Open the report | |
| NATIONAL KIDNEY FOUNDATION | NATIONAL KIDNEY FOUNDATIONSecond quarter of 2026 | $80,000reported as expenses |
| Open the report |
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together, rounded to the nearest $10,000. A report under $5,000 states no figure. It is not the amount spent on one bill.
Reports read: 0 of 1 quarters read in full (2026-Q2). With no registered key the service allows 15 requests a minute, so this covers the latest quarter only. With a key it covers four.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
All saved lobbying reports that name H.R. 1518
Contributions from these lobbyists and firms to the sponsor and cosponsors
| To | Reported by | Paid to, as reported | Amount | Date |
|---|---|---|---|---|
| Brian K. Fitzpatrick RRepublicanCosponsor | OTSUKA AMERICA PHARMACEUTICAL INC. PACfiled by OTSUKA AMERICA PHARMACEUTICAL, INC., a registrant that filed a lobbying report naming this bill (same LDA registrant number 401093052) | BRIAN FITZPATRICK FOR ALL OF USHonoree: Rep. Brian Kevin Fitzpatrick | $1,000 | Open the report |
Contribution reports are read for 6 of the 64 sponsors and cosponsors so far.
Lobbyists and registrants report their political contributions twice a year (form LD-203). A contribution is listed here when the report was filed by a lobbyist named on this bill's lobbying reports or by a registrant that filed one of them, and its payee is the member's own committee as the FEC lists it, under the exact-name rule. The contribution's date is as reported and can fall before or after the lobbying.